Recent

% | $
Quotes you view appear here for quick access.

Response Genetics, Inc Message Board

  • twm48976 twm48976 Aug 9, 2013 2:03 PM Flag

    RGDXthe fact that 2Q13 gross margins of 49% is among the highest in oncology testing services group

    Is reason enough to buy more here. So I will

    Response Genetics target raised to $2.75 at Ladenburg Thalmann as revenue growth gathers momentum

    Ladenburg Thalmann raises their RGDX tgt to $2.75 from $1.75 based on the top line growth story, co's competitive cost structure, and the fact that 2Q13 gross margins of 49% is among the highest in oncology testing services group. The firm's core thesis for RGDX remains unchanged: it views co as a restructuring story entering the midpoint of its turnaround strategy.

    Sentiment: Strong Buy

 
RGDX
0.122+0.002(+1.58%)Jul 31 3:56 PMEDT